SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB/A - Optional form for quarterly and transition reports of small business issuers: [Amend]
SEC Accession No. 0001009919-06-000026
Filing Date
2006-08-02
Accepted
2006-08-01 21:20:17
Documents
6
Period of Report
2005-07-31

Document Format Files

Seq Description Document Type Size
1 AMERSIN AMENDED Q2-05 A1 f051020amls10qsbq2ammended.htm 10QSB/A 133875
2 f051020amls10qsbq2ammende010.gif GRAPHIC 805587
3 f051020amls10qsbq2ammende002.gif GRAPHIC 809079
4 f051020amls10qsbq2ammende004.gif GRAPHIC 753093
5 f051020amls10qsbq2ammende006.gif GRAPHIC 772355
6 f051020amls10qsbq2ammende008.gif GRAPHIC 798595
  Complete submission text file 0001009919-06-000026.txt   5562978
Mailing Address TIAN YUAN, 5TH FLOOR XIANGYI HOTEL, BAOFENG ER LU HANKOU, WUHAN F4 999999
Business Address TIAN YUAN, 5TH FLOOR XIANGYI HOTEL, BAOFENG ER LU HANKOU, WUHAN F4 999999 604-881-2899
Amersin Life Sciences CORP (Filer) CIK: 0001009919 (see all company filings)

IRS No.: 880419476
Type: 10QSB/A | Act: 34 | File No.: 000-25553 | Film No.: 06995880
SIC: 2834 Pharmaceutical Preparations